The TOE1 gene helps your cells process and trim small RNA molecules, which supports normal brain and nerve cell function. When both copies of this gene do not work properly, a rare inherited condition can develop that affects early brain growth and movement. This condition is called pontocerebellar hypoplasia type 7. People with severe TOE1 variants may have low muscle tone, developmental delay, feeding difficulties, and changes in the cerebellum and pons, parts of the brain that help control coordination and basic body functions.
What is a gene?
Genes are sections of DNA that carry instructions cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins that act as the working parts of cells. Other genes mainly help determine when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to explore this topic more deeply, you can find more in the LearnHub.
Overview
TOE1Gene function
What if the gene works
The TOE1 gene helps cells finish and clean up small RNA molecules, especially those needed for RNA splicing. This supports accurate gene reading and steady cell function, which is especially important in nerve cells.
Risk
What if the gene does not work
More severe variants in the TOE1 gene can cause a rare condition with underdevelopment of parts of the brain, leading to developmental delay, low muscle tone, and movement, feeding, or breathing problems. Milder variants may cause a less severe course.
Treatment
What does that mean for your treatment
No TOE1-specific treatment or management approach is currently established for pathogenic variants in the TOE1 gene. Research is exploring how changes in TOE1 affect RNA handling in cells, but this has not yet led to a targeted medicine.
Conditions associated with TOE1
Gene function
What if the gene works
Your cells rely on the TOE1 gene to help finish and check certain RNA molecules, especially small RNAs used in the cell nucleus. One of the main jobs of the TOE1 gene in human cells is helping these RNAs reach their final usable form. This steady cleanup supports smooth day to day gene activity.
TOE1 helps trim the ends of small nuclear RNAs, or snRNAs (small helper RNAs). This gives them the right final shape so they can work properly in the nucleus.
It removes extra tail pieces from immature RNAs and helps clear RNAs that are not fully ready. This quality control keeps the cell's RNA supply more orderly and usable.
Many RNAs handled by TOE1 help with splicing (editing gene messages before proteins are made). By keeping these helper RNAs mature, TOE1 supports accurate day to day protein production.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help explain normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants shorten or destabilize the TOE1 gene's protein, leaving cells with less working protein and poorer trimming of certain small RNA tails. Milder changes may leave some activity, while more disruptive variants can nearly abolish it. This spectrum helps explain how TOE1 gene variants affect RNA processing in cells and, in people with two severe variants, may be linked to earlier and more pronounced features of pontocerebellar hypoplasia.
How variants are linked to conditions
Pathogenic variants in the TOE1 gene cause pontocerebellar hypoplasia type 7, a rare inherited condition affecting brain growth and development. In clinical genetics, the TOE1 gene and pontocerebellar hypoplasia type 7 are closely linked. People with this diagnosis often have marked developmental delay, low muscle tone, feeding difficulties, and changes in head and brain growth.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most have no direct impact on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental influences play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For TOE1, risk is mainly shaped by genetics rather than day-to-day habits. Risk is higher in children who inherit a harmful TOE1 change from both parents, especially in families with a known history of the condition; there is not broadly confirmed evidence that lifestyle or environmental factors change this risk.
Inheritance of TOE1 variants
TOE1-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit one altered copy of the TOE1 gene from each parent to be affected, while parents with one altered copy are typically carriers and usually do not have the condition. When both parents carry a TOE1 gene variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child who inherits neither variant. This is the main way TOE1 variants are inherited in families.
What does my TOE1 result mean for my family?
For families with a disease-causing TOE1 result linked to a TOE1-related condition, the pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be carriers or, less often, also have the condition. Close relatives may want to learn whether the same family change is present, especially when there is a history of similar symptoms or pregnancy loss. Future children in the family could also be affected if both parents carry a disease-causing TOE1 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the TOE1 gene, doctors can use TOE1 genetic testing on a blood or saliva sample. The lab reads the DNA code of the gene, often as part of a larger panel or exome test, and reports whether a relevant variant is found.
When should I consider getting a genetic test?
Genetic testing for the TOE1 gene may be worth considering when a baby or child has signs of a rare inherited condition affecting early brain development, such as severe developmental delay, a very small head size, low muscle tone, or brain scan changes. It can also help when similar problems run in the family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies with the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more quickly, while others process it more slowly, which can change how much of the medicine reaches the body over time. These differences are common and can influence how well a treatment works or how likely someone is to notice side effects. Medication response is shaped by genetics along with factors like age, liver and kidney function, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape how people respond to medicines. It studies patterns between genes and drugs to clarify why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, personalized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the TOE1 gene
When should I seek medical advice?
There is no widely confirmed evidence that changes in this gene affect how medicines work, so any questions about symptoms, side effects, or treatment choices are best discussed with your doctor.
History
In the early 2000s, researchers identified the TOE1 gene while studying proteins involved in RNA processing, the cell’s system for handling genetic messages. It was first described as part of efforts to map and name human genes with roles in basic cell function. From these first observations, research expanded steadily. Later work connected the TOE1 gene to the function of small structures in the cell nucleus called Cajal bodies, which help assemble important RNA machinery. In the 2010s, genetic studies linked harmful variants in the TOE1 gene to a rare inherited neurologic condition, helping clarify its medical importance. These findings turned TOE1 from a little known gene into one recognized in rare disease genetics.